Skip to main content

Now Accepting Applications for the Early Childhood Staff Stipend Incentive Program!

Individuals must be active members of The Nevada Registry AND working in an eligible program to apply. To determine whether you are eligible, log into your Online Portal account and click on the 'Membership Account' tab on your dashboard. If you are eligible, you will see a tab titled, 'Early Childhood Staff Stipend Incentive Program' under your membership profile. APPLICATIONS WILL BE ACCEPTED THROUGH APRIL 2023.

Learn More About the Staff Stipend

Technical bulletin from state health officials provides clinical guidance.

The U.S. Food and Drug Administration (FDA) has authorized the emergency use of the Moderna COVID-19 vaccine and the Pfizer-BioNTech COVID-19 vaccine for the prevention of COVID-19 to include use in children under five years of age.

On June 18, the day after FDA authorization, the Advisory Committee on Immunization Practices (ACIP) unanimously voted to recommend the use of the Moderna COVID-19 vaccine two-dose primary series for children ages six months to five years and the Pfizer three-dose series for children ages six months to four years. According to disease burden data to the ACIP, children ages six months through four years are at risk of severe COVID -19 infection and more than two million cases of the illness have been identified among this population. COVID-19-associated hospitalizations among children ages six months through four years have similar severity compared to older children and adolescents and more than half of the hospitalized children ages six months through four years had no underlying conditions. The burden of COVID-19 associated death among this population is similar to or exceeds that of other pediatric vaccine-preventable diseases.

For more information, including vaccine administration guidance, see the technical bulletin on this topic posted to the Division of Public and Behavioral Health Technical Bulletins web page.

For more information, guidance and resources about the COVID-19 response in Nevada, visit